Skip to content
My WebMD Sign In, Sign Up
FDA Approves New Drug for Relapsing MS
avatar
Elizabeth_WebMD_Staff posted:
In a two-year study, the Aubagio reduced yearly relapses by nearly a third compared to placebo and also slowed the progression of the disease. This new med will be prescribed for relapsing forms of MS.

FDA Approves New MS Drug Aubagio

For more info about the study see this information from the National Multiple Sclerosis Society.

Will you be talking with your doctor about this?

Elizabeth
Reply


Featuring Experts

Neil S. Lava, MD, is the director of the multiple sclerosis clinic at Emory University in Atlanta. He has been treating multiple sclerosis patients si...More

Helpful Tips

certified nursing assistant (CNA)
I am a care giver who have had vast experience with MS patient and i do travel with my client/s. If some one out there who is looking for a ... More
Was this Helpful?
1 of 1 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.